This study adds to the body of literature supporting the beneficial effects of semaglutide in people with overweight and obesity without diabetes, which is so necessary as we continue to navigate the complex landscape of insurance coverage of these medications in people who do not have diabetes, Shiara Ortiz-Pujols, MD, MPH, an obesity medicine physician at Staten Island University Hospital, told Healthline
Nature 498 , 99103 (2013)
Loh HH, Lim QH, Chai CS, et al
Metabolic Health Is the Bigger Picture Even if a patients first concern is appearance, medical weight loss should focus on overall health
By promoting collagen synthesis, CJC 1295 helps keep skin firm, smooth, and more resistant to the signs of aging a surprising key player in longevity and aesthetics
What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)